Average Co-Inventor Count = 5.02
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (32 from 3,935 patents)
2. Irm LLC (5 from 151 patents)
32 patents:
1. 10028955 - FGFR inhibitor for use in the treatment of hypophosphatemic disorders
2. 9890166 - Imidazopyrrolidine derivatives and their use in the treatment of disease
3. 9714249 - Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
4. 9624247 - Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
5. 9556180 - Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction
6. 9550796 - Pyrrolopyrrolone derivatives and their use as BET inhibitors
7. 9403827 - Substituted purinone compounds
8. 9365576 - Pyrrolopyrrolidinone compounds
9. 8975417 - Pyrazolopyrrolidine derivatives and their use in the treatment of disease
10. 8969341 - Pyrazolopyrrolidine compounds
11. 8940771 - Organic compounds
12. 8859586 - Cyclohexyl isoquinolinone compounds
13. 8815901 - Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors
14. 8815926 - Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases
15. 8759517 - Pyrirnidinyl aryl urea derivatives being FGF inhibitors